MedTrace Logo

The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders

NCT07021404 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50000

Last updated 2025-06-15

No results posted yet for this study

Summary

The objective of this study is to collect data in Flanders on the incidence of suicide attempts and suicidal ideation across various healthcare settings. The study also aims to assess the proportion of individuals who receive adequate aftercare following a suicide attempt and to systematically document the methods and means used in suicidal behavior.

Conditions

  • Suicidal Ideation
  • Suicide Attempt
  • Multicenter Study
  • Epidemiological Study
  • Suicidal Behavior

Interventions

OTHER

Semi-structured interview (Guideline for Suicide care and Evaluation =LOES)

A semi-structured interview is utilized in general hospitals and other healthcare institutions by clinicians and nurses as part of the psychosocial assessment, with the aim of collecting standardized data on episodes of self-harm and individuals experiencing suicidal ideation. The interview consists of two parts: Part 1 is administered shortly after admission to the healthcare facility due to an episode of self-harm or reported suicidal thoughts. It is conducted by a trained nurse or psychologist. This section collects demographic information, characteristics of the self-harm episode, history of self-harm behavior, perceived social support, level of hopelessness, and current suicidal ideation. Part 2 focuses on a more in-depth exploration of the individual's psychological state. It assesses underlying motives for the self-harm or suicidal thoughts, perceived personal and interpersonal problems, and current and current thoughts of self-harm.

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Gwendolyn Portzky, Prof · University Ghent

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-12-31
Primary Completion
2033-03-31
Completion
2033-03-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07021404 on ClinicalTrials.gov